Welcome to the Wealth Daily Weekend Edition — our insights from the week in investing and links to our most-read Wealth Daily and sister publication articles.
If there is logic to the markets these days, it goes something like this: Good news is good and bad news is even better…
I mean, not even the brewing collapse of the Eurozone or the Congressional takedown of Goldman Sachs can stop this run, as the markets continue to grind higher.
So much I guess for the famed "Wall of Worry"…
In fact, even the weekly chart of the DOW is about to turn even more bullish with a second consecutive close above the 200-week moving average. Take a look:
That’s the mojo that is helping pushing stocks to rebound highs, as the bears slink even deeper into cold, dark woods.
As for places to lay down your bets, I still like the biotech sector, where the right breaking story can earn you a small fortune.
That’s what happened yesterday for Dendreon (NASDAQ: DNDN) investors as the company went on a moonshot after the FDA approved its cancer vaccine, Provenge. After they resumed trading, DNDN shares jumped over 30% instantaneously.
But that’s nothing compared to the call our own Ian Cooper made on the company a year ago, when he was urging Wealth Daily readers to buy Dendreon at just $6.00 a share. Today it’s up over 500%. Great call, Ian.
As for some new investment ideas, there are a few below from the pages of this week’s top-read articles in Wealth Daily and our sister publications, Energy & Capital and Green Chip Stocks.
If you can’t find a stock in there that looks good to you… well, the next bull market will likely be moving on without you.
Until next time, have a great weekend.
Your bargain-hunting analyst,
Steve Christ
Editor, Wealth Daily
The Hottest Domestic Oil Play in Decades: Playing Petro Supply and Demand for Profit
Wealth Daily Publisher Brian Hicks comments on the state of energy in the United States and around the globe and explains why we’re in a perfect storm for investment in oil.
Part-time Forex Profit Raider: Finally, A Currency Trading Plan for the Rest of Us
A click-and-profit system so simple that it allows you to profit in the Forex market over breakfast, on your lunch break, after catching up on the evening news? Sounds too good to be true… but it’s not. Read more to find out how you can cash in on $550-$2200 a week with this simple system.
50 Blue Chips for the Next Bull Market: 50 Blue Chips for the Next Bull Market
Wealth Daily‘s Steve Christ unveils his Nifty Fifty Blue Chip Stock Index and explains why these household names will lead the next bull market.
A Giant’s Golden Gaffe: Say Hello to the Easiest Gains You’ll Make this Summer
This one’s for the books. Top metals investor Greg McCoach explains how one company’s multi-billion dollar goof just created the easiest gains you’ll make this summer.
How the Bakken Oil Formation Just Got 50% Bigger: Breaking News from North Dakota
Energy & Capital’s Keith Kohl reveals a new study confirming nearly 2 billion barrels of recoverable oil — below the Bakken.
The Future of Nuclear Energy: Obama Warming Up to the N-word
Energy & Capital Editor Nick Hodge talks about the future of Nuclear Energy as dozens of new reactors are being built in China, India, and — yes, even the United States.
One Wicked Cheap Fuel Cell Stock: Ballard Power, A Promising Fuel Cell Stock
Editor at large and trader extraordinaire Christian DeHaemer names not one but two cheap fuel cell stocks— and a battery maker to boot.
Start-up Smart Grid Companies: 2 Smart Grid Companies with IPO Implications
Green Chip Stocks Editor Nick Hodge explains how to profit from the Smart Grid and names two of the hottest potential new IPOs.
Deadbeat Homeowners Boost Retail Spending: How Strategic Defaults Are Driving Consuming Behavior
Wealth Daily Editor Ian Cooper explains what’s really driving consumer spending & how to profit as millions just walk away.
Top American Wind Energy Companies: 10 American Wind Energy Companies You Should Know
Green Chips Stocks guru Jeff Siegel names ten domestic wind companies that are sure to please those looking to "Buy American".
The Biotech Bull: This Market is Just Heating Up
Wealth Daily Editor Steve Christ discusses the biotech bull market and the one overlooked American company that just made your immune system 1,000 times more effective.
